Titre:
  • DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
Auteur:Drouillard, Antoine; Puleo, Francesco; Bachet, Jean-Baptiste; Ouazzani, Sohaib; Calomme, Annabelle; Demetter, Pieter; Verset, Gontran; Van Laethem, Jean-Luc; Marechal, Raphaël
Informations sur la publication:British Journal of Cancer, 115, 10, page (1245-1252)
Statut de publication:Publié, 2016-11
Sujet CREF:Cancérologie
Mots-clés:biomarker
DLL4
immunohistochemistry
Notch1
Notch3
pancreatic cancer
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0007-0920
info:doi/10.1038/bjc.2016.319
info:pii/bjc2016319
info:scp/84991687082
info:pmid/27755532
info:ulb-repo/set/1#38770